Literature DB >> 25841426

Opioid-induced hyperalgesia after rapid titration with intravenous morphine: Switching and re-titration to intravenous methadone.

Sebastiano Mercadante1, Patrizia Ferrera2, Edoardo Arcuri3, Alessandra Casuccio4.   

Abstract

BACKGROUND: Rapid titration with intravenous morphine (IV-MO) provides fast and efficient pain relief in cancer patients with severe-excruciating pain. However, some patients, after an initially favourable response, can develop an hyperexcitated state unrelieved or worsened by further dose increments.
METHODS: Eighty-one patients admitted on emergency basis titrated with IV-MO were assessed.
RESULTS: 12 patients were unsuccessfully titrated with IV-MO. Switching to intravenous methadone (IV-ME) and titrating the doses proved to be successfully.
CONCLUSIONS: In escalating opioid doses rapidly a recognition of the development of hyperalgesia should be suspected. Increasing doses of opioids may stimulate rather than inhibiting the central nervous system, with complex mechanisms already recognized in experimental studies. Switching to IV-ME and titrating the doses could be taken into consideration to break this vicious circle before pain conditions worsen irreversibly.

Entities:  

Keywords:  Cancer pain; opioid switching; opioid titration; opioid-induced hyperalgesia

Year:  2012        PMID: 25841426     DOI: 10.3978/j.issn.2224-5820.2012.01.02

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  7 in total

1.  Opioid Induced Hyperalgesia, a Research Phenomenon or a Clinical Reality? Results of a Canadian Survey.

Authors:  Grisell Vargas-Schaffer; Suzie Paquet; Andrée Neron; Jennifer Cogan
Journal:  J Pers Med       Date:  2020-04-21

2.  Intraoperative methadone for postoperative pain management - systematic review protocol.

Authors:  Zhaosheng Jin; Erica J Lin; Yaohua He; Jun Lin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2019-10-15

Review 3.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

4.  Mechanisms, diagnosis, prevention and management of perioperative opioid-induced hyperalgesia.

Authors:  Sylvia H Wilson; Kevin M Hellman; Dominika James; Adam C Adler; Arvind Chandrakantan
Journal:  Pain Manag       Date:  2021-03-29

5.  Methadone and Ketamine: Boosting Benefits and Still More to Learn.

Authors:  Evan D Kharasch; J David Clark
Journal:  Anesthesiology       Date:  2021-05-01       Impact factor: 7.892

6.  Pain in the management of opioid use disorder.

Authors:  Sunil Sirohi; Amit K Tiwari
Journal:  J Pain Res       Date:  2016-11-04       Impact factor: 3.133

7.  Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.

Authors:  Launette Marie Rieb; Wendy V Norman; Ruth Elwood Martin; Jonathan Berkowitz; Evan Wood; Ryan McNeil; M-J Milloy
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.